Financhill
Back

Zentalis Pharmaceuticals Stock Predictions

Zentalis Pharmaceuticals Stock Forecast

  • Is Zentalis Pharmaceuticals Stock Undervalued?
    The current Zentalis Pharmaceuticals [ZNTL] share price is $1.48. The Score for ZNTL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ZNTL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Zentalis Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Zentalis Pharmaceuticals Stock Rating

Data Unavailable

Zentalis Pharmaceuticals Stock Price History

Is ZNTL stock going to rise?

  • The current trend is moderately bullish and ZNTL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
zentalis.com

52-Week Data

52-Week High:
10.68
52-Week Low:
1.01

Prediction Charts

Market Cap:
106.5M
Price in USD:
1.48
Volume:
853.9K
Beta:
1.60

Technical Analysis

SMA50:
1.31
SMA100:
1.67
SMA200:
2.48
52-Wk Change:
-85.19%

Stock Predictions

  • Is Zentalis Pharmaceuticals stock public?
    Yes, Zentalis Pharmaceuticals is a publicly traded company.
  • What is the Zentalis Pharmaceuticals stock quote today?
    The Zentalis Pharmaceuticals stock price is 1.48 USD today.
  • How to buy Zentalis Pharmaceuticals stock online?
    You can buy Zentalis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-22 1.20 1.24 1.24 1.18
May-23 1.22 1.20 1.22 1.19
May-27 1.21 1.20 1.23 1.18
May-28 1.19 1.25 1.26 1.18
May-29 1.25 1.25 1.27 1.22
May-30 1.23 1.21 1.24 1.20
Jun-2 1.23 1.28 1.28 1.19
Jun-3 1.28 1.36 1.40 1.24
Jun-4 1.34 1.50 1.51 1.29
Jun-5 1.51 1.47 1.60 1.46
Jun-6 1.48 1.52 1.56 1.45
Jun-9 1.53 1.49 1.58 1.45
Jun-10 1.49 1.63 1.67 1.49
Jun-11 1.63 1.48 1.64 1.48

Zentalis Pharmaceuticals Earnings

Data Unavailable

Zentalis Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.15 per share, an increase this year of $0.19 per share, and an increase next year of $0.16 per share.

* Zentalis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.